Summary

Persistence Market Research has recently released a comprehensive report on the global Norovirus Diagnostics Market, providing an in-depth analysis of the market's key dynamics, including drivers, trends, opportunities, and challenges. This report offers valuable insights into the market structure and growth potential.

Key Highlights:

• Norovirus Diagnostics Market Size (2024E): USD 63.8 Million
• Projected Market Value (2033F): USD 134 Million
• Global Market Growth Rate (CAGR 2024 to 2033): 8.6%

Norovirus Diagnostics Market Overview:

The Norovirus Diagnostics Market includes a range of techniques and devices designed for the accurate diagnosis of norovirus infections, a leading cause of acute gastroenteritis worldwide. These diagnostic tools are essential for timely and precise virus detection, facilitating appropriate treatment and preventing outbreaks. The market caters to various segments such as hospitals, diagnostic laboratories, and point-of-care testing facilities. Market growth is primarily driven by the rising incidence of norovirus outbreaks, advancements in diagnostic technologies, and the increasing use of rapid diagnostic tests in diverse healthcare settings.

Market Growth Drivers:

Several factors are propelling the growth of the global Norovirus Diagnostics Market. The increasing incidence of norovirus infections worldwide is driving the demand for accurate and timely diagnostic solutions. Technological advancements, such as the development of rapid antigen detection tests and molecular diagnostics, have enhanced the speed and accuracy of norovirus detection, further contributing to market expansion. Additionally, growing awareness of norovirus-related health risks and the implementation of infection control measures are boosting demand. Increased R&D efforts and the introduction of innovative diagnostic devices are also contributing to market growth by offering more specialized solutions for healthcare providers and patients.

Market Restraints:

Despite the positive growth outlook, the Norovirus Diagnostics Market faces challenges, including the high costs of advanced diagnostic techniques and the risks associated with false-negative results. Market growth may also be limited by the availability of alternative diagnostic methods, such as symptom-based clinical diagnosis, which some healthcare providers may prefer due to their simplicity. Moreover, concerns about the accessibility of advanced diagnostic methods in low-resource settings pose additional challenges. Addressing these issues will require continued investment in R&D to enhance the accuracy, affordability, and accessibility of norovirus diagnostics.

Market Opportunities:

The market offers significant opportunities driven by the growing adoption of molecular diagnostics and rapid antigen detection tests, which provide improved accuracy and speed in norovirus detection. The development of advanced diagnostic technologies, such as multiplex assays and next-generation sequencing, meets the increasing demand for more precise and comprehensive diagnostic options. Expanding healthcare infrastructure in emerging markets also presents new growth avenues, enabling companies to reach a larger patient base and offer access to cutting-edge diagnostic methods. Strategic partnerships, investments in healthcare professional training, and patient-centered approaches will be crucial for leveraging emerging opportunities and maintaining market leadership.

Key Questions Addressed in the Report:

• What are the main drivers of growth in the global Norovirus Diagnostics Market?
• Which diagnostic types and techniques are most widely adopted in various healthcare settings?
• How are technological advancements shaping the competitive landscape of the Norovirus Diagnostics Market?
• Who are the leading players in the Norovirus Diagnostics Market, and what strategies are they using to stay competitive?
• What are the emerging trends and future prospects in the global Norovirus Diagnostics Market?

Competitive Intelligence and Business Strategy:

Key players in the global Norovirus Diagnostics Market, including BioMerieux SA, DiaSorin S.p.A., and Luminex Corporation, are focusing on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies are investing in R&D to develop advanced diagnostic solutions and explore new detection technologies. Collaborations with healthcare providers, research institutions, and technology developers are enhancing market access and promoting the adoption of new products. Emphasis on patient education, high-quality products, and comprehensive training programs is driving market growth and strengthening brand loyalty in the evolving Norovirus Diagnostics Market landscape.

Key Companies Profiled:

• Abbott
• R-Biopharm AG
• Cepheid
• Luminex Corporation
• Meridian Bioscience
• ELITechGroup
• BioMérieux SA
• CerTest Biotec S.L.
• Elisabeth Pharmacon, Spol. S Ro
• Qiagen
• Altona Diagnostics GmbH
• Eiken Chemical Co

Norovirus Diagnostics Market Segmentation:

By Product:

• Rapid Test Kits
• PCR Kits
• ELISA-Based Kits

By End-User:

• Hospitals
• Diagnostic Labs
• Clinics

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption Analysis
4.2. Key Regulations
4.3. Recent Product launches/ Approvals
4.4. PESTEL Analysis
4.5. Key Promotional Strategies, By Key Players
4.6. Porter’s Analysis
4.7. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.1.3. Global Viral Testing Diagnostic Kits Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Rising prevalence of Norovirus
5.2.2. Increasing Demand for Rapid Testing
5.2.3. Technological Advancement
5.2.4. Awareness and growing government funding
5.2.5. Rising initiatives by public and private organizations
5.2.6. Growth of Norovirus Diagnostics Centers
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By End User
6.1.3. By Country
6.2. 2022 Market Scenario
7. Global Norovirus Diagnostics Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2023
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2024-2033
8.3.1. Rapid Test Kits
8.3.2. PCR Kits
8.3.3. ELISA based kits
8.4. Market Attractiveness Analysis By Product
9. Global Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
9.3.1. Hospitals
9.3.2. Diagnostics laboratories
9.3.3. Clinics
9.4. Market Attractiveness Analysis By End User
10. Global Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, By Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
10.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, By Region, 2024-2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Product
11.3.3. By End User
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Product
11.4.3. By End User
11.5. Market Trends
11.6. Drivers and Restraints - Impact Analysis
11.7. Key Players - Intensity Mapping
11.8. Country Level Analysis & Forecast
11.8.1. U.S. Norovirus Diagnostics Market Analysis
11.8.1.1. Introduction
11.8.1.2. Market Analysis and Forecast by Market Taxonomy
11.8.1.2.1. By Product
11.8.1.2.2. By End User
11.8.2. Canada Norovirus Diagnostics Market Analysis
11.8.2.1. Introduction
11.8.2.2. Market Analysis and Forecast by Market Taxonomy
11.8.2.2.1. By Product
11.8.2.2.2. By End User
12. Latin America Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
12.3.1. By Country
12.3.1.1. Mexico
12.3.1.2. Brazil
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Product
12.3.3. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product
12.4.3. By End User
12.5. Market Trends
12.6. Drivers and Restraints - Impact Analysis
12.7. Key Players - Intensity Mapping
12.8. Country Level Analysis & Forecast
12.8.1. Mexico Norovirus Diagnostics Market Analysis
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast by Market Taxonomy
12.8.1.2.1. By Product
12.8.1.2.2. By End User
12.8.2. Brazil Norovirus Diagnostics Market Analysis
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast by Market Taxonomy
12.8.2.2.1. By Product
12.8.2.2.2. By End User
12.8.3. Argentina Norovirus Diagnostics Market Analysis
12.8.3.1. Introduction
12.8.3.2. Market Analysis and Forecast by Market Taxonomy
12.8.3.2.1. By Product
12.8.3.2.2. By End User
13. Europe Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. U.K.
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Russia
13.3.1.8. Rest of Europe
13.3.2. By Product
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By End User
13.5. Market Trends
13.6. Drivers and Restraints - Impact Analysis
13.7. Key Players - Intensity Mapping
13.8. Country Level Analysis & Forecast
13.8.1. Germany Norovirus Diagnostics Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Product
13.8.1.2.2. By End User
13.8.2. Italy Norovirus Diagnostics Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Product
13.8.2.2.2. By End User
13.8.3. France Norovirus Diagnostics Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast by Market Taxonomy
13.8.3.2.1. By Product
13.8.3.2.2. By End User
13.8.4. U.K. Norovirus Diagnostics Market Analysis
13.8.4.1. Introduction
13.8.4.2. Market Analysis and Forecast by Market Taxonomy
13.8.4.2.1. By Product
13.8.4.2.2. By End User
13.8.5. Spain Norovirus Diagnostics Market Analysis
13.8.5.1. Introduction
13.8.5.2. Market Analysis and Forecast by Market Taxonomy
13.8.5.2.1. By Product
13.8.5.2.2. By End User
13.8.6. BENELUX Norovirus Diagnostics Market Analysis
13.8.6.1. Introduction
13.8.6.2. Market Analysis and Forecast by Market Taxonomy
13.8.6.2.1. By Product
13.8.6.2.2. By End User
13.8.7. Russia Norovirus Diagnostics Market Analysis
13.8.7.1. Introduction
13.8.7.2. Market Analysis and Forecast by Market Taxonomy
13.8.7.2.1. By Product
13.8.7.2.2. By End User
14. East Asia Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
14.3.1. By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.2. By Product
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By End User
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Key Players - Intensity Mapping
14.8. Country Level Analysis & Forecast
14.8.1. China Norovirus Diagnostics Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By End User
14.8.2. Japan Norovirus Diagnostics Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By End User
14.8.3. South Korea Norovirus Diagnostics Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Product
14.8.3.2.2. By End User
15. South Asia Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Indonesia
15.3.1.3. Malaysia
15.3.1.4. Thailand
15.3.1.5. Rest of South Asia
15.3.2. By Product
15.3.3. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By End User
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Key Players - Intensity Mapping
15.8. Country Level Analysis & Forecast
15.8.1. India Norovirus Diagnostics Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By End User
15.8.2. Indonesia Norovirus Diagnostics Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By End User
15.8.3. Malaysia Norovirus Diagnostics Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By End User
15.8.4. Thailand Norovirus Diagnostics Market Analysis
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast by Market Taxonomy
15.8.4.2.1. By Product
15.8.4.2.2. By End User
16. Oceania Norovirus Diagnostics Market 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Product
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By End User
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Key Players - Intensity Mapping
16.8. Country Level Analysis & Forecast
16.8.1. Australia Norovirus Diagnostics Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By End User
16.8.2. New Zealand Norovirus Diagnostics Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By End User
17. Middle East and Africa (MEA) Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Turkey
17.3.1.3. North Africa
17.3.1.4. South Africa
17.3.1.5. Rest of Middle East and Africa
17.3.2. By Product
17.3.3. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By End User
17.5. Market Trends
17.6. Drivers and Restraints - Impact Analysis
17.7. Key Players - Intensity Mapping
17.8. Country Level Analysis & Forecast
17.8.1. GCC Countries Norovirus Diagnostics Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By End User
17.8.2. Turkey Norovirus Diagnostics Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By End User
17.8.3. South Africa Norovirus Diagnostics Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By End User
17.8.4. North Africa Norovirus Diagnostics Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Product
17.8.4.2.2. By End User
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Deep Dive
19.2.1. Abbott
19.2.1.1. Overview
19.2.1.2. Product Portfolio
19.2.1.3. Sales Footprint
19.2.1.4. Key Financials
19.2.1.5. SWOT Analysis
19.2.1.6. Strategy Overview
19.2.1.6.1. Marketing Strategy
19.2.1.6.2. Product Strategy
19.2.1.6.3. Channel Strategy
19.2.2. R-Biopharm AG
19.2.2.1. Overview
19.2.2.2. Product Portfolio
19.2.2.3. Sales Footprint
19.2.2.4. Key Financials
19.2.2.5. SWOT Analysis
19.2.2.6. Strategy Overview
19.2.2.6.1. Marketing Strategy
19.2.2.6.2. Product Strategy
19.2.2.6.3. Channel Strategy
19.2.3. Cepheid
19.2.3.1. Overview
19.2.3.2. Product Portfolio
19.2.3.3. Sales Footprint
19.2.3.4. Key Financials
19.2.3.5. SWOT Analysis
19.2.3.6. Strategy Overview
19.2.3.6.1. Marketing Strategy
19.2.3.6.2. Product Strategy
19.2.3.6.3. Channel Strategy
19.2.4. Luminex Corporation
19.2.4.1. Overview
19.2.4.2. Product Portfolio
19.2.4.3. Sales Footprint
19.2.4.4. Key Financials
19.2.4.5. SWOT Analysis
19.2.4.6. Strategy Overview
19.2.4.6.1. Marketing Strategy
19.2.4.6.2. Product Strategy
19.2.4.6.3. Channel Strategy
19.2.5. Meridian Bioscience
19.2.5.1. Overview
19.2.5.2. Product Portfolio
19.2.5.3. Sales Footprint
19.2.5.4. Key Financials
19.2.5.5. SWOT Analysis
19.2.5.6. Strategy Overview
19.2.5.6.1. Marketing Strategy
19.2.5.6.2. Product Strategy
19.2.5.6.3. Channel Strategy
19.2.6. ELITechGroup
19.2.6.1. Overview
19.2.6.2. Product Portfolio
19.2.6.3. Sales Footprint
19.2.6.4. Key Financials
19.2.6.5. SWOT Analysis
19.2.6.6. Strategy Overview
19.2.6.6.1. Marketing Strategy
19.2.6.6.2. Product Strategy
19.2.6.6.3. Channel Strategy
19.2.7. Biomérieux SA
19.2.7.1. Overview
19.2.7.2. Product Portfolio
19.2.7.3. Sales Footprint
19.2.7.4. Key Financials
19.2.7.5. SWOT Analysis
19.2.7.6. Strategy Overview
19.2.7.6.1. Marketing Strategy
19.2.7.6.2. Product Strategy
19.2.7.6.3. Channel Strategy
19.2.8. CerTest Biotec S.L.
19.2.8.1. Overview
19.2.8.2. Product Portfolio
19.2.8.3. Sales Footprint
19.2.8.4. Key Financials
19.2.8.5. SWOT Analysis
19.2.8.6. Strategy Overview
19.2.8.6.1. Marketing Strategy
19.2.8.6.2. Product Strategy
19.2.8.6.3. Channel Strategy
19.2.9. Elisabeth Pharmacon, Spol. S Ro
19.2.9.1. Overview
19.2.9.2. Product Portfolio
19.2.9.3. Sales Footprint
19.2.9.4. Key Financials
19.2.9.5. SWOT Analysis
19.2.9.6. Strategy Overview
19.2.9.6.1. Marketing Strategy
19.2.9.6.2. Product Strategy
19.2.9.6.3. Channel Strategy
19.2.10. Qiagen
19.2.10.1. Overview
19.2.10.2. Product Portfolio
19.2.10.3. Sales Footprint
19.2.10.4. Key Financials
19.2.10.5. SWOT Analysis
19.2.10.6. Strategy Overview
19.2.10.6.1. Marketing Strategy
19.2.10.6.2. Product Strategy
19.2.10.6.3. Channel Strategy
19.2.11. Altona Diagnostics GmbH
19.2.11.1. Overview
19.2.11.2. Product Portfolio
19.2.11.3. Sales Footprint
19.2.11.4. Key Financials
19.2.11.5. SWOT Analysis
19.2.11.6. Strategy Overview
19.2.11.6.1. Marketing Strategy
19.2.11.6.2. Product Strategy
19.2.11.6.3. Channel Strategy
19.2.12. Eiken Chemical Co
19.2.12.1. Overview
19.2.12.2. Product Portfolio
19.2.12.3. Sales Footprint
19.2.12.4. Key Financials
19.2.12.5. SWOT Analysis
19.2.12.6. Strategy Overview
19.2.12.6.1. Marketing Strategy
19.2.12.6.2. Product Strategy
19.2.12.6.3. Channel Strategy
20. Assumptions and Acronyms Used
21. Research Methodology